Drug Approval | November 01, 2023
Lupin Mandideep plant gets USFDA green signal
The inspection of the facility conducted from August 7 to August 11, 2023
The inspection of the facility conducted from August 7 to August 11, 2023
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
The European Commission approved the use of Carbopol as an additive for liquid and solid food supplements in the EU
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)
In the Phase 3 LIBRETTO-431 study, Retevmo more than doubled progression-free survival (PFS) compared to chemotherapy plus pembrolizumab in patients with advanced or metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC)
The company expects that this development could improve the strength of its application to the FDA for new drug approval
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
Investment is additive to KKR’s existing health care growth strategy
Subscribe To Our Newsletter & Stay Updated
